D-0356-2021 Class II Ongoing
FDA drug recall D-0356-2021 was initiated by Teligent Pharma, Inc. on Apr 9, 2021 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: The recall status is ongoing. Affected quantity: 3432 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 28, 2021
- Initiation Date
- Apr 9, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3432 tubes
Product description
Flurandrenolide Ointment USP, 0.05%, Net Wt. 60 grams, Rx Only, Teligent Pharma, Inc. Buena, New Jersey 08310 NDC 52565-017-60
Reason for recall
Failed Impurities/Degradation Specifications:
Distribution pattern
Distributed Nationwide in the USA
Code information
Lot #13974 EXP 7/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0356-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026